Brain Connectivity in Treatment Resistant Depression
common.study.values.description
“Structural and Functional Connectivity of Brainstem Monoamine Pathways in Treatment Resistant Depression”
Study TRD subjects' resistance to at least 2 different antidepressants, we hypothesize that because of their significant depression and treatment resistant status they are most likely to exhibit BSMN pathway abnormalities.
common.study.values.location
participant.ui.study.affiliations-map.online-study.header-virtual
participant.ui.study.affiliations-map.online-study.text
common.study.values.methods


Drug - Monoamine Oxidase Inhibitor (MAOI)
Monoamine Oxidase Inhibitor
participant.views.study.view.additional
participant.views.study.view.scientific-title
Structural and Functional Connectivity of Brainstem Monoamine Pathways in Treatment Resistant Depression
common.study.values.clinical-trial-id
NCT03109717
participant.views.study.view.id
mbk0Ed